Fig. 4
Response criteria fulfilled after 1-year. UpsSet plot showing the number and proportion of patients who met 1–4 key criteria for clinical response to benralizumab. Each column represents the percentage of patients who met one or several pre-defined criteria after 1 year of follow-up. Percentages are calculated over the total number of patients with valid data. Key clinical outcomes included absence of severe exacerbations, asthma symptom control as defined by an ACT score ≥ 20, lung function improvement as defined by an increase in FEV1 ≥ 100 mL and no use of OCS. “n” represents the number of patients who met the specified criteria, while “N” represents the total number of patients with available data. ACT, asthma control test; BD, bronchodilator; FEV1, forced expiratory volume in 1 s; OCS, oral corticosteroids